医学
彭布罗利珠单抗
贝伐单抗
黑色素瘤
肿瘤科
内科学
脑转移
临床研究阶段
癌症
临床试验
癌症研究
化疗
免疫疗法
转移
作者
Sarah A. Weiss,Dijana Djureinovic,Wei Wei,Thuy Tran,Matthew R Austin,Joseph Markowitz,Zeynep Eroglu,Nikhil I. Khushalani,Upendra P. Hegde,Justine V. Cohen,Mario Sznol,Gail D. Anderson,Barbara Johnson,Cecily Piteo,Amit Mahajan,Adebowale Adeniran,Lucia B. Jilaveanu,Sarah B. Goldberg,Veronica Chiang,Peter Forsyth
摘要
Pembrolizumab with bevacizumab was well tolerated and demonstrated substantial activity in patients with untreated MBM with promising OS, justifying further evaluation of this regimen.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
zzzz
贪玩的秋柔
大力的灵雁
AllRightReserved
HH
wanci
畔畔
lizishu
科研狗
乐空思
GingerF
浮浮世世
dew
湖工大保卫处
昏睡的蟠桃
Rich
Mic
殷勤的紫槐
MP
皖公网安备34019202002308
